WORLD CONGRESS ON GASTROINTESTINAL CANCER
2023 World Congress on Gastrointestinal Cancer28 June-1 July Barcelona
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| 1-P | Gastric cancer: Artificial intelligence, complex system analysis and simulation for best management | Oleg Kshivets |  Received |
 |
|||
| 5-P | A Soluble resistance related calcium binding protein (Sorcin) up-regulates in the multi-drug resistant advanced gastric cancer patients | Sushmita Ghosh | Received |
|
|||
| 8-PD | HERIZON: A Phase 2 study of HER-Vaxx (IMU-131), a HER2-targeting peptide vaccine plus SOC chemotherapy in patients with HER2 advanced stomach Cancer-Correlation of the antibody responses and clinical outcome | Joshua Tobias | Received |
|
|||
| 13-P | Management of Metastatic Colorectal Cancer in Patients &8805;70 Years - A Single Center Experience | Florian Huemer | Received |
|
|||
| 20-P | Pseudoglandular pattern in hepatocellular neoplasms and its diagnostic value with cytokeratin immunostain | Lee-Ching Zhu | Received |
|
|||
| 27-PD | The use of pre-operative systemic oxaliplatin or irinotecan doublet chemotherapy in colorectal cancer peritoneal metastases (CRPM): Results from a single UK peritoneal tumour centre | Nadina Tinsley | Received |
|
|||
| 48-P | Outcomes of early gall bladder cancer (GBCA): A retrospective analysis from a tertiary care centre in India | Joydeep Ghosh | Received |
|
|||
| 68-P | Impact of specimens and fixation status on HER2 assessment in the treatment of advanced gastric cancer (HER_WEEKEND study) | Michio Nakamura | Received |
|
|||
| 77-P | Multisite intratumoral chemotherapy improves treatment outcome in a murine model with pancreatic ductal adenocarcinoma | Ron Epelbaum | Received |
|
|||
| 104-P | Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Preliminary results from a multi-cohort, multi-center phase II trial (ALTER-G-001) | Huimin Wang | Received |
|
|||
| 120-P | Efficacy of systemic therapy for advanced hepatocellular carcinoma based on etiology: a systematic review and network meta-analysis | Charlene Hoi Lam Wong | Received |
|
|||
| 135-P | Detection of RAS gene mutations in patients with metastatic colorectal cancer during cetuximab-based first-line treatment and survival of the patients in relation to changes in RAS gene status | Marian Stresko | Received |
|
|||
| 175-P | Next-generation sequencing in colorectal cancer patients: characterization and prognostic implications | Federico Longo | Received |
|
|||
| 210-P | Efficacy and tolerability of cetuximab 750 mg/m2 every three weeks in metastatic colorectal cancer | Mohamed Aseafan | Received |
|
|||
| 221-P | Prediction of colon cancer recurrence based on proteomic biomarkers | Soledad Cameselle-Garcia | Received |
|
|||
| 240-P | Frequency and management of trifluridine/tipiracil (FTD/TPI) bevacizumab (BEV)-associated neutropenia in patients with refractory metastatic colorectal cancer (mCRC) in real-world practice | Nieves Martínez Lago | Received |
|
|||
| 278-P | Survival impact and predictive scores for thrombosis associated with pancreatic ductal adenocarcinoma (PDAC) | Alejandra Romano | Received |
|
|||
| 333-P | Retrospective analysis of second-line chemotherapy after Folfirinox failure in advanced pancreatic cancer | Yana Chikhareva | Received |
|
|||
| 419-P | Safety and effectiveness analysis of neoadjuvant chemoradiation plus consolidative chemotherapy with concurrent anti-pd-1 therapy in mid-low locally advanced rectal cancer | Xinliang Liu | Received |
|
|||
2023 World Congress on Gastrointestinal Cancer
28 June-1 July Barcelona
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 28/06/2023 TO 28/06/2024
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
Poster submission deadline 14/06/2023
|
|
